Breaking News

Nykode Therapeutics Selects BioConnection to Manufacture Lead Vax Candidate

BioConnection has more than fifteen years of experience and serves a global customer base.

Author Image

By: Charlie Sternberg

Associate Editor

BioConnection, an independent CDMO based in The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, has announced that Nykode Therapeutics AS, (formerly Vaccibody), selected BioConnection for the aseptic drug product manufacturing of its lead vaccine candidate.   Nykode Therapeutics is a clinical stage biotechnology company, developing vaccines and novel immunotherapies for the treatment of cancer and infectious diseases with a high unmet med...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters